Source: International Congress 2019 – Understanding lung disease: novel in vitro models
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Kim (London, United Kingdom), R. Mongey (London, United Kingdom), P. Wang (London, United Kingdom), M. Hind (London, United Kingdom), M. Griffiths (London, United Kingdom), C. Dean (London, United Kingdom). LSC - 2019 - A novel ex-vivo approach to study lung injury and repair. 1899

Member's Comments

No comment yet.

Related content which might interest you: LSC - 2021 - Lung-on-a-chip device for modelling of ventilator induced lung injury Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 LSC - 2021 - Establishment of a human in vitro model for airway epithelial repair and regeneration Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 Ex vivo elastase and hydrogen peroxide stimulation in lung slices: novel models to study lung repair Source: International Congress 2016 – Therapeutic horizons: novel targets and pharmacological models Year: 2016 Development of a porcine model to study donor lung injury Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 LSC - 2021 - Elastin-like-recombinamer cryogel as a platform for lung regeneration Source: Virtual Congress 2021 – In vitro modelling of lung disease: reach out to the next dimension Year: 2021 LSC - 2017 - Targeting glucose metabolism in experimental lung injury and fibrosis Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 LSC - 2017 - Senolytic drugs target alveolar epithelial cell function and attenuate experimental lung fibrosis ex vivo Source: International Congress 2017 – Cellular signalling pathways in pulmonary fibrosis Year: 2017 LSC - 2021 - A comprehensive guide to pulmonary mesenchymal populations in the healthy and IPF lung. Source: Virtual Congress 2021 – Cellular and molecular involvement in lung injury and repair Year: 2021 LSC - 2021 - Use of differentiated primary human airway epithelial models to study SARS-CoV-2 infection biology and pathogenesis Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection Year: 2021 A novel approach for optimal lung recruitment in acute lung injury Source: Annual Congress 2005 - Pulmonary function outcome, respiratory morbidity in prematurely born children and acute lung injury Year: 2005 LSC - 2017 - Mouse lung adenocarcinoma cell lines as tools to identify novel lung cancer genes Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 LSC - 2017 - The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: International Congress 2017 – Functional genomics knowledge in parenchymal and bronchial diseases Year: 2017 FDG-microPET imaging to comfirm brain death in a mouse model: A useful tool to study related donor lung injury Source: Annual Congress 2010 - New clinical and experimental insights in lung transplantation Year: 2010 The use of a murine model of brain death for mechanistic studies on treatment for donor lung injury Source: Annual Congress 2011 - Improving outcomes after lung transplantation Year: 2011 Fluorescence bronchoscopy (FB) to detect the early lung cancer developement in high-risk aysmptomatic individuals - a pilot study initial results Source: Eur Respir J 2001; 18: Suppl. 33, 63s Year: 2001 LSC - 2019 - Relevant murine model to study the development of COPD pathogenesis in smokers with viral infections Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms Year: 2019 Methods of identification lung cancer stem cells: a pilot study. Source: International Congress 2017 – Basic research in lung cancer: a scientific potpourri from genetic alterations to immune cells Year: 2017 Ex vivo lung repair: rebuilding a new lung Source: Annual Congress 2013 –What's new in thoracic surgery: highlights for the pulmonologist Year: 2013 LSC - 2019 - Validating immunoproteasome activity as a potential biomarker in non-invasive samples from COPD patients Source: International Congress 2019 – Immunopathological mechanisms of lung disease Year: 2019